Third Wave's Q4 Revenues up 31 Percent, But Loss Rises on R&D, Litigation Costs | GenomeWeb
NEW YORK (GenomeWeb News) – Third Wave Technologies today reported that its revenue grew nearly 31 percent in the fourth quarter of 2007, but its net loss climbed nearly 72 percent on increased R&D and legal expenses. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.